Welcome to our dedicated page for Wiley (JOHN) & Sons SEC filings (Ticker: WLYB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The John Wiley & Sons, Inc. (WLYB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into Wiley’s financial performance, capital allocation decisions, governance, and strategic priorities in research publishing, research intelligence, learning solutions, and AI-related initiatives.
Among the most closely watched filings for WLYB are Form 10-K annual reports and Form 10-Q quarterly reports, which contain segment information for Research and Learning, discussions of demand to publish, read, and license content, and commentary on open access models, AI licensing revenue, and market conditions in academic and professional learning. Investors can also review how Wiley presents non-GAAP measures such as Adjusted EPS, Adjusted Operating Income and Margin, Adjusted EBITDA and Margin, and Free Cash Flow, along with reconciliations to GAAP figures.
Current reports on Form 8-K for WLYB document material events such as quarterly earnings announcements, increases in share repurchase allocations under the company’s authorization, dividend changes, Board appointments, and executive leadership updates. These filings often reference press releases that describe trends in research growth, AI momentum, and margin expansion, as well as decisions on dividends and repurchases.
Definitive proxy statements on Form DEF 14A provide information about Wiley’s Board of Directors, executive compensation, governance practices, and the company’s long-term mission to provide must-have knowledge and insights while embracing responsible AI. Together, these filings help investors understand how Wiley manages its Research and Learning businesses, approaches capital allocation, and positions itself within the scholarly and information ecosystem.
On Stock Titan, WLYB filings are supplemented with AI-powered summaries designed to make complex disclosures more accessible. These summaries can help readers quickly interpret key points from lengthy 10-K and 10-Q reports, 8-K event disclosures, and proxy materials, while links to the original EDGAR documents preserve full detail for deeper analysis.
John Wiley & Sons, Inc. (WLYB) filed a Form 144 indicating a proposed sale of 5,300 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $229,490. The filing lists seven tranches of stock acquired through the lapse of performance- and restricted-stock units (PSUs/RSUs) between 30-Jun-2024 and 30-Apr-2025. No prior sales were reported during the last three months.
The shares to be sold represent only 5,300 of the company’s 44,624,949 shares outstanding, a fraction that is immaterial to the public float. The notice certifies that the seller is not in possession of undisclosed material adverse information and that the trade is scheduled for approximately 02-Jul-2025.
- Issuer: John Wiley & Sons, Inc.
- Form: 144 – Notice of Proposed Sale under Rule 144
- Broker: UBS Financial Services, Weehawken, NJ
- Method: Ordinary market sale on NYSE
- Seller holdings source: PSU/RSU lapses; not gifts or open-market purchases
This filing is routine for insiders seeking to resell shares obtained via equity compensation and, given the small size relative to total shares outstanding, is unlikely to have a material impact on WLYB’s capital structure or market liquidity.
Christopher Caridi, SVP and Chief Accounting Officer of John Wiley & Sons, reported receiving 2,221 Restricted Stock Units (RSUs) on June 25, 2025. The RSUs convert to Class A common stock on a one-for-one basis.
Key details of the grant:
- Vesting occurs in four equal annual installments starting April 30th of each year after grant
- RSUs are subject to forfeiture under grant terms and conditions
- The grant was priced at $0, as typical for RSU awards
- Total RSU holdings after this grant: 10,184 units
This Form 4 filing represents standard equity compensation for an executive officer, with the transaction executed under normal insider trading reporting requirements. The grant aligns management interests with shareholders through long-term vesting requirements.
Jay Flynn, EVP & GM of Research & Learning at John Wiley & Sons, received a grant of 12,337 restricted stock units (RSUs) on June 25, 2025. The RSUs convert to Class A common stock on a one-for-one basis.
Key details of the grant:
- Vesting occurs in four equal annual installments starting April 30th of each year after grant
- RSUs are subject to forfeiture under grant terms and conditions
- The grant was priced at $0, as typical for RSU awards
- Following this transaction, Flynn owns a total of 38,440 RSUs
This Form 4 filing represents a standard equity compensation grant to a senior executive, indicating continued alignment of management incentives with shareholder interests through long-term vesting requirements.
Danielle McMahan, EVP and Chief People Officer of John Wiley & Sons, reported receiving 7,659 Restricted Stock Units (RSUs) on June 25, 2025. The RSUs convert to Class A common stock on a one-for-one basis.
Key details of the grant:
- The RSUs will vest in four equal annual installments starting April 30th of each year following the grant
- The grant was priced at $0 as compensation
- Subject to forfeiture under grant terms and conditions
- McMahan now holds a total of 25,591 RSUs including this new grant
This Form 4 filing was submitted by attorney-in-fact Deirdre P. Silver on June 27, 2025, reporting the transaction under Section 16(a) of the Securities Exchange Act of 1934.